MDWD
NASDAQ
$14.28
MediWound Ltd (MDWD)
MediWound Ltd., a biopharmaceutical company, develops, manufactures and markets new and biotherapeutic solutions for tissue repair and regeneration. The company is headquartered in Yavne, Israel.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $30.17 (+111.27%)
Market Cap
$183M
FCF 5Y CAGR
+22.79%
Free Cash Flow Yield
-13.77%
Beta (5Y)
0.85
Price Chart
Valuation
Market Cap$183M
Forward P/E34.97
P/S12.65
P/B4.42
Profitability
Total Revenue (TTM)$14M
Gross Profit (TTM)$2.84M
EBITDA-$15M
Profit Margin-180.3%
Operating Margin-541%
EPS-$2.26
Financial Health
Debt-to-Equity19.6%
Free Cash Flow Yield-13.77%
Growth & Risk
EPS 5Y CAGR-1.74%
Revenue 5Y CAGR-8.98%
FCF 5Y CAGR+22.79%
Beta (5Y)0.85
Sharpe Ratio-0.64